We are live on ! Find out more
SRRA

Sierra Oncology, Inc. Common Stock
SRRA

Delisted

SRRA was delisted on the 30th of June, 2022.

Back to rankings

41 hedge funds and large institutions have $45M invested in Sierra Oncology, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more capital invested

Capital invested by funds: $34.1M → $45M (+$11M)

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

3% more funds holding

Funds holding: 40 → 41 (+1)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

Holders
41
Holders Change
+1
Holders Change %
+2.5%
% of All Funds
1.02%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
6
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$2.2M
2
Millennium Management
Millennium Management
New York
+$1.34M
3
IHM
Iguana Healthcare Management
New York
+$880K
4
Renaissance Technologies
Renaissance Technologies
New York
+$311K
5
SIM
Spark Investment Management
New York
+$277K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$1.66M
2
DM
Deerfield Management
New York
-$1.02M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$669K
4
AIC
AWM Investment Company
New York
-$585K
5
NC
Nexthera Capital
New York
-$468K
Name Holding Trade Value Shares
Change 		Change in
Stake
RJT
26
Raymond James Trust
Florida
$45K – – –
DS
27
DRW Securities
Illinois
$39K – – –
RC
28
RBF Capital
California
$39K – – –
PNC Financial Services Group
29
PNC Financial Services Group
Pennsylvania
$36K – – –
ARTA
30
A.R.T. Advisors
New York
$35K +$33.3K +567 New
COI
31
Connable Office Inc
Michigan
$25K – – –
Acadian Asset Management
32
Acadian Asset Management
Massachusetts
$24K +$1.06K +18 +5%
GC
33
Guggenheim Capital
Illinois
$23K +$22K +375 New
Connor, Clark & Lunn Investment Management (CC&L)
34
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$19K -$880 -15 -5%
Wells Fargo
35
Wells Fargo
California
$14K – – –
Parallax Volatility Advisers
36
Parallax Volatility Advisers
California
$10K +$9.91K +169 New
UBS Group
37
UBS Group
Switzerland
$8K +$7.51K +128 New
Bank of America
38
Bank of America
North Carolina
$2K – – –
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$2K – – –
RE
40
RBC Europe
United Kingdom
$1.51K +$1.41K +24 New
CSS
41
Cubist Systematic Strategies
Connecticut
$1K +$997 +17 New
AIC
42
AWM Investment Company
New York
– -$585K -12,500 Closed
NC
43
Nexthera Capital
New York
– -$468K -10,000 Closed
VMI
44
VHCP Management II
New York
– -$153K -3,270 Closed
WS
45
Wedbush Securities
California
– -$41K -875 Closed
Citadel Advisors
46
Citadel Advisors
Florida
– -$13K -275 Closed
Manulife (Manufacturers Life Insurance)
47
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$1K -18 Closed
1
2

SRRA Hedge Fund Activity: Q3 2017 in Review

41 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Sierra Oncology, Inc. Common Stock (SRRA) for Q3 2017, worth a combined $45M — up 32% from $34.1M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new SRRA positions and 8 closed out — a net gain of 1 holder — while 6 added to existing stakes and 8 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $2.2M. The largest seller was Sabby Management, cutting an estimated $1.66M.

  • 41 institutional investors held Sierra Oncology, Inc. Common Stock (SRRA) as of Q3 2017, up from 40 in Q2 2017.
  • Funds reported $45M of Sierra Oncology, Inc. Common Stock stock for Q3 2017, up 32% quarter-over-quarter.
  • 9 funds opened new Sierra Oncology, Inc. Common Stock positions in Q3 2017 and 8 closed out, a net change of +1 holder.
  • The largest Sierra Oncology, Inc. Common Stock buyer in Q3 2017 was Point72 Asset Management, an estimated $2.2M added.
  • The largest Sierra Oncology, Inc. Common Stock seller in Q3 2017 was Sabby Management, an estimated $1.66M sold.

Based on aggregated 13F filings for Q3 2017.